Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy.
about
Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Adiponectin and the steatosis ...... -based antiretroviral therapy.
@en
Adiponectin and the steatosis ...... -based antiretroviral therapy.
@nl
type
label
Adiponectin and the steatosis ...... -based antiretroviral therapy.
@en
Adiponectin and the steatosis ...... -based antiretroviral therapy.
@nl
prefLabel
Adiponectin and the steatosis ...... -based antiretroviral therapy.
@en
Adiponectin and the steatosis ...... -based antiretroviral therapy.
@nl
P2093
P2860
P1433
P1476
Adiponectin and the steatosis ...... I-based antiretroviral therapy
@en
P2093
Anoma Somasunderam
David Reynoso
Jordan Lake
Judith Currier
Netanya Utay
P2860
P304
P356
10.1371/JOURNAL.PONE.0196395
P407
P577
2018-05-10T00:00:00Z